TW200600099A - Therapeutic or preventive agent for eye disease - Google Patents

Therapeutic or preventive agent for eye disease

Info

Publication number
TW200600099A
TW200600099A TW094116160A TW94116160A TW200600099A TW 200600099 A TW200600099 A TW 200600099A TW 094116160 A TW094116160 A TW 094116160A TW 94116160 A TW94116160 A TW 94116160A TW 200600099 A TW200600099 A TW 200600099A
Authority
TW
Taiwan
Prior art keywords
therapeutic
preventive agent
eye disease
eye diseases
cataract
Prior art date
Application number
TW094116160A
Other languages
Chinese (zh)
Inventor
Mikio Sugano
Sumie Goto
Hideyuki Yamato
Michihito Ise
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of TW200600099A publication Critical patent/TW200600099A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A therapeutic or preventive agent for eye diseases which contains spherical activated carbon as an active ingredient. The therapeutic or preventive agent is effective, without causing any side effect, for eye diseases such as cataract, retinopathy, glaucoma, macular degeneration, and retinal hemorrhage.
TW094116160A 2004-05-18 2005-05-18 Therapeutic or preventive agent for eye disease TW200600099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004148021 2004-05-18

Publications (1)

Publication Number Publication Date
TW200600099A true TW200600099A (en) 2006-01-01

Family

ID=35393993

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094116160A TW200600099A (en) 2004-05-18 2005-05-18 Therapeutic or preventive agent for eye disease

Country Status (3)

Country Link
JP (1) JPWO2005110444A1 (en)
TW (1) TW200600099A (en)
WO (1) WO2005110444A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11292770A (en) * 1998-04-10 1999-10-26 Kureha Chem Ind Co Ltd Matrix formation sthenia inhibitor
JP3522708B2 (en) * 2001-04-11 2004-04-26 呉羽化学工業株式会社 Adsorbent for oral administration

Also Published As

Publication number Publication date
WO2005110444A1 (en) 2005-11-24
JPWO2005110444A1 (en) 2008-03-21

Similar Documents

Publication Publication Date Title
WO2008140052A1 (en) Prophylactic or therapeutic agent for posterior ocular disease comprising ropinirole or salt thereof as active ingredient
WO2007035473A3 (en) Pharmaceutical delivery device and method for providing ocular treatment
EP2662089A3 (en) Compstatin and analogs thereof for eye disorders
WO2007043052A3 (en) Device, system and method for dual-path ophthalmic device
WO2007076360A8 (en) (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
MX2009005644A (en) Gel useful for the delivery of ophthalmic drugs.
TW200744574A (en) Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement of medicament for ophthalmic use in the form of eye-drops
WO2012071476A3 (en) Drug eluting ocular implant
WO2007012061A3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
WO2006042329A3 (en) Crig polypeptide for prevention and treatment of complement-associated disorders
MX2010003774A (en) Aqueous ophthalmic formulations.
WO2009137085A8 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
WO2006014484A3 (en) Methods and devices for the treatment of ocular conditions
MX2007007614A (en) Preventive or therapeutic agent for glaucoma.
WO2007046083A3 (en) Compositions for treatment of eye diseases
MX2009001745A (en) Treatment of ocular diseases.
HK1110221A1 (en) Use of prodrugs for ocular intravitreous administration
BR0317026A (en) Superoxide dismutase mimics for the treatment of eye disorders and diseases
CL2007002386A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment and / or prophylaxis of selected diseases of macular degeneration, neovascularization or angiogenesis of the cornea, iris or retina, diabetic and non-diabetic retinopathy.
MX2008015976A (en) Topical treatment for diseases of eye surface.
HK1069785A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
WO2007089673A3 (en) Compositions and methods for treatment of ophthalmic diseases and disorders
EP1752158A4 (en) Corneal neuritogenesis promoter containing pacap and its derivative
TW200600099A (en) Therapeutic or preventive agent for eye disease